Copyright Reports & Markets. All rights reserved.

Global Digital Companion Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Polymerase Chain Reaction (PCR)
    • 1.4.3 Immunohistochemistry (IHC)
    • 1.4.4 In Situ Hybridization (ISH)
    • 1.4.5 Next Generation Sequencing (NGS)
  • 1.5 Market by Application
    • 1.5.1 Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Pharmaceutical Companies
    • 1.5.4 Laboratories
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Digital Companion Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Digital Companion Diagnostics Growth Trends by Regions
    • 2.2.1 Digital Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Digital Companion Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Digital Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Digital Companion Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Digital Companion Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Digital Companion Diagnostics Players by Market Size
    • 3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Digital Companion Diagnostics Market Concentration Ratio
    • 3.2.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2019
  • 3.3 Digital Companion Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Digital Companion Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Digital Companion Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Digital Companion Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Digital Companion Diagnostics Market Size (2015-2020)
  • 6.2 Digital Companion Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Digital Companion Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Digital Companion Diagnostics Market Size (2015-2020)
  • 7.2 Digital Companion Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Digital Companion Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Digital Companion Diagnostics Market Size (2015-2020)
  • 8.2 Digital Companion Diagnostics Key Players in China (2019-2020)
  • 8.3 China Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Digital Companion Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Digital Companion Diagnostics Market Size (2015-2020)
  • 9.2 Digital Companion Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Digital Companion Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Digital Companion Diagnostics Market Size (2015-2020)
  • 10.2 Digital Companion Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Digital Companion Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Digital Companion Diagnostics Market Size (2015-2020)
  • 11.2 Digital Companion Diagnostics Key Players in India (2019-2020)
  • 11.3 India Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Digital Companion Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Digital Companion Diagnostics Market Size (2015-2020)
  • 12.2 Digital Companion Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Digital Companion Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Digital Companion Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Roche Holdings (Switzerland)
    • 13.1.1 Roche Holdings (Switzerland) Company Details
    • 13.1.2 Roche Holdings (Switzerland) Business Overview
    • 13.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Introduction
    • 13.1.4 Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2015-2020))
    • 13.1.5 Roche Holdings (Switzerland) Recent Development
  • 13.2 Abbott Laboratories (US)
    • 13.2.1 Abbott Laboratories (US) Company Details
    • 13.2.2 Abbott Laboratories (US) Business Overview
    • 13.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Introduction
    • 13.2.4 Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.2.5 Abbott Laboratories (US) Recent Development
  • 13.3 Thermo Fisher Scientific (US)
    • 13.3.1 Thermo Fisher Scientific (US) Company Details
    • 13.3.2 Thermo Fisher Scientific (US) Business Overview
    • 13.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Introduction
    • 13.3.4 Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.3.5 Thermo Fisher Scientific (US) Recent Development
  • 13.4 Agilent Technologies (US)
    • 13.4.1 Agilent Technologies (US) Company Details
    • 13.4.2 Agilent Technologies (US) Business Overview
    • 13.4.3 Agilent Technologies (US) Digital Companion Diagnostics Introduction
    • 13.4.4 Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.4.5 Agilent Technologies (US) Recent Development
  • 13.5 Life Technologies (US)
    • 13.5.1 Life Technologies (US) Company Details
    • 13.5.2 Life Technologies (US) Business Overview
    • 13.5.3 Life Technologies (US) Digital Companion Diagnostics Introduction
    • 13.5.4 Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.5.5 Life Technologies (US) Recent Development
  • 13.6 GE Healthcare (UK)
    • 13.6.1 GE Healthcare (UK) Company Details
    • 13.6.2 GE Healthcare (UK) Business Overview
    • 13.6.3 GE Healthcare (UK) Digital Companion Diagnostics Introduction
    • 13.6.4 GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.6.5 GE Healthcare (UK) Recent Development
  • 13.7 Agendia (Angola)
    • 13.7.1 Agendia (Angola) Company Details
    • 13.7.2 Agendia (Angola) Business Overview
    • 13.7.3 Agendia (Angola) Digital Companion Diagnostics Introduction
    • 13.7.4 Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.7.5 Agendia (Angola) Recent Development
  • 13.8 Qiagen (Germany)
    • 13.8.1 Qiagen (Germany) Company Details
    • 13.8.2 Qiagen (Germany) Business Overview
    • 13.8.3 Qiagen (Germany) Digital Companion Diagnostics Introduction
    • 13.8.4 Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.8.5 Qiagen (Germany) Recent Development
  • 13.9 Genomic Health (US)
    • 13.9.1 Genomic Health (US) Company Details
    • 13.9.2 Genomic Health (US) Business Overview
    • 13.9.3 Genomic Health (US) Digital Companion Diagnostics Introduction
    • 13.9.4 Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.9.5 Genomic Health (US) Recent Development
  • 13.10 Myriad Genetics (US)
    • 13.10.1 Myriad Genetics (US) Company Details
    • 13.10.2 Myriad Genetics (US) Business Overview
    • 13.10.3 Myriad Genetics (US) Digital Companion Diagnostics Introduction
    • 13.10.4 Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 13.10.5 Myriad Genetics (US) Recent Development
  • 13.11 Advanced Cell Diagnostics (US)
    • 10.11.1 Advanced Cell Diagnostics (US) Company Details
    • 10.11.2 Advanced Cell Diagnostics (US) Business Overview
    • 10.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Introduction
    • 10.11.4 Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 10.11.5 Advanced Cell Diagnostics (US) Recent Development
  • 13.12 Danaher (US)
    • 10.12.1 Danaher (US) Company Details
    • 10.12.2 Danaher (US) Business Overview
    • 10.12.3 Danaher (US) Digital Companion Diagnostics Introduction
    • 10.12.4 Danaher (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 10.12.5 Danaher (US) Recent Development
  • 13.13 Applied Proteomics (US)
    • 10.13.1 Applied Proteomics (US) Company Details
    • 10.13.2 Applied Proteomics (US) Business Overview
    • 10.13.3 Applied Proteomics (US) Digital Companion Diagnostics Introduction
    • 10.13.4 Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
    • 10.13.5 Applied Proteomics (US) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Digital Companion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Digital Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Roche Holdings (Switzerland)
    Abbott Laboratories (US)
    Thermo Fisher Scientific (US)
    Agilent Technologies (US)
    Life Technologies (US)
    GE Healthcare (UK)
    Agendia (Angola)
    Qiagen (Germany)
    Genomic Health (US)
    Myriad Genetics (US)
    Advanced Cell Diagnostics (US)
    Danaher (US)
    Applied Proteomics (US)

    Market segment by Type, the product can be split into
    Polymerase Chain Reaction (PCR)
    Immunohistochemistry (IHC)
    In Situ Hybridization (ISH)
    Next Generation Sequencing (NGS)
    Market segment by Application, split into
    Hospitals
    Pharmaceutical Companies
    Laboratories
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now